Evidence map›Paper›PMID 38055184›Full record

ArticleCEN case reports2024

A case of bullous pemphigoid and renal disease after dipeptidyl peptidase 4 inhibitor administration.

Atsuhiko Suenaga, Naoki Sawa, Yuki Oba, Daisuke Ikuma, Akinari Sekine, Masayuki Yamanouchi, Eiko Hasegawa, Hiroki Mizuno, Tatsuya Suwabe, Nobukazu Hayashi and 6 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in CEN case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Atsuhiko SuenagaDepartment of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, 1-3-1, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan. atsuhiko4822gh@gmail.com.
Naoki SawaDepartment of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, 1-3-1, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.
Yuki ObaDepartment of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, 1-3-1, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.
Daisuke IkumaDepartment of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, 1-3-1, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.
Akinari SekineDepartment of Nephrology and Rheumatology, Toranomon Hospital, Tokyo, Japan.
Masayuki YamanouchiDepartment of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, 1-3-1, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.
Eiko HasegawaDepartment of Nephrology and Rheumatology, Toranomon Hospital, Tokyo, Japan.
Hiroki MizunoDepartment of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, 1-3-1, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.
Tatsuya SuwabeDepartment of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, 1-3-1, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.
Nobukazu HayashiDepartment of Dermatology, Toranomon Hospital, Tokyo, Japan.
Kei KonoDepartment of Pathology, Toranomon Hospital, Tokyo, Japan.
Keiichi KinowakiDepartment of Pathology, Toranomon Hospital, Tokyo, Japan.
Kenichi OhashiDepartment of Pathology, Toranomon Hospital, Tokyo, Japan.
Motoaki MiyazonoDepartment of Nephrology, Saga University Internal Medicine, Saga, Japan.
Yutaka YamaguchiYamaguchi's Pathology Laboratory, Chiba, Japan.
Yoshifumi UbaraDepartment of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, 1-3-1, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan.
Toranomon Hospital · JPSaga University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 62-year-old man with type 2 diabetes was admitted because of a decrease in estimated glomerular filtration rate from 72 to 17.5 mL/min/1.73 m

Indexed as

Diabetes Mellitus, Type 2Dipeptidyl-Peptidase IV InhibitorsPemphigoid, BullousBiopsyGlomerular Filtration RateGlycated HemoglobinHumansMaleMiddle AgedNephritis, InterstitialSkinDipeptidyl-Peptidase IV InhibitorsGlycated HemoglobinBullous pemphigoidDiabetic nephropathyDipeptidyl peptidase-4 inhibitorGlomerular endothelial cell injury

Identifiers

PMID38055184
PMCPMC11294501
OpenAlexW4389390114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.